Arix Bioscience plc (ARIX.L)
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.
Company Info
Highlights
£185.67M
£0.11
12.91
£115.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Arix Bioscience plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ARIX.L
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
4.22%
2.22%
9.51%
22.46%
12.74%
11.29%
Monthly Returns
The table below presents the monthly returns of ARIX.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 13.89% | 12.70% | |||||||||||
| 2023 | 0.00% | 11.16% | -11.30% | -0.94% | -0.00% | -4.29% | 13.93% | 0.44% | 8.70% | -5.60% | -5.08% | 12.50% | 17.21% |
| 2022 | 1.25% | -2.06% | -1.68% | -2.56% | -1.32% | -1.78% | -3.62% | 10.33% | -11.06% | 3.83% | -4.15% | 3.37% | -10.42% |
| 2021 | -23.52% | 12.84% | 0.53% | 0.00% | -6.84% | -1.13% | 1.71% | -2.81% | -12.43% | -10.23% | -3.68% | -8.40% | -45.21% |
| 2020 | -10.33% | -13.61% | -29.09% | 41.03% | 15.76% | -9.42% | -15.61% | 7.53% | 42.04% | -5.38% | 41.23% | 46.98% | 105.63% |
| 2019 | 2.10% | -6.76% | -5.99% | 4.03% | -3.87% | -8.72% | -7.72% | -12.75% | 2.74% | 4.44% | -11.91% | 2.90% | -36.04% |
| 2018 | -2.56% | 9.21% | -5.54% | -1.53% | 7.51% | -4.82% | -12.15% | 2.31% | -1.41% | -7.14% | 5.54% | -2.92% | -14.62% |
| 2017 | -0.48% | -5.05% | 2.53% | 1.98% | 0.06% | -3.45% | -6.02% | 6.93% | -4.74% | -5.76% | 8.33% | -6.70% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Arix Bioscience plc (ARIX.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Arix Bioscience plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Arix Bioscience plc was 73.17%, occurring on Mar 31, 2020. Recovery took 188 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -73.17% | Mar 19, 2018 | 516 | Mar 31, 2020 | 188 | Dec 29, 2020 | 704 |
| -56.31% | Dec 30, 2020 | 634 | Jul 10, 2023 | — | — | — |
| -18.33% | Jun 8, 2017 | 54 | Aug 22, 2017 | 132 | Mar 1, 2018 | 186 |
| -15.07% | Feb 20, 2017 | 33 | Apr 5, 2017 | 38 | Jun 2, 2017 | 71 |
| -0.46% | Mar 13, 2018 | 1 | Mar 13, 2018 | 2 | Mar 15, 2018 | 3 |
Volatility
Volatility Chart
The current Arix Bioscience plc volatility is 4.06%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Arix Bioscience plc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |